Daria Maria Monti | Biochemistry | Best Academic Researcher Award

Published on by Biotechnology Scientist

Prof. Daria Maria Monti | biochemistry | Best Academic Researcher Award

Associate Professor at University of Naples Federico II, Italy

Daria Maria Monti (DMM) is an accomplished Associate Professor in the Department of Chemical Sciences at the University of Naples Federico II, with an impressive track record in cellular biology and biochemistry. She is widely recognized for her investigations into the cytotoxic effects of noble metal compounds and the antioxidant properties of natural extracts, as well as her more recent work on microalgae as a source of bioactive molecules. DMM has published over 100 peer-reviewed articles and has earned an h-index of 32, with more than 2700 citations to date, reflecting her significant contributions to the scientific community. Her academic and research influence extends globally through numerous speaking engagements and collaborative projects.

Profile

Scopus

Education

DMM’s educational foundation in biochemical sciences laid the groundwork for her future in biomedical research. She pursued advanced postdoctoral training internationally, notably at the Center for Biochemical and Biophysical Sciences and Medicine, Harvard Medical School, under the mentorship of esteemed scientists Prof. Vallee and Prof. Riordan from 1999 to 2001. Her education continued with a visiting scientist position at Tufts Medical Center’s Molecular Oncology Research Institute in 2012, where she explored molecular responses in cancer biology. These formative experiences helped hone her expertise in oxidative stress and therapeutic compounds.

Experience

Over the years, DMM has accumulated extensive experience in both academic and applied research settings. Her primary appointments have involved cellular biology and biochemistry, with a growing emphasis on natural antioxidants and cytotoxic agents. Beyond laboratory research, she has served as an evaluator for multiple national and European scientific projects, and as a reviewer for numerous high-impact international journals. DMM has been deeply involved in academic mentorship, acting as a tutor and co-supervisor for students in Molecular and Industrial Biotechnology and Health Biotechnology programs. Since 2014, she has also contributed to the PhD School in Biotechnology, mentoring several doctoral candidates across multiple academic cycles.

Research Interest

DMM’s research interests are deeply rooted in understanding the mechanisms of oxidative stress and cellular defense systems. Her work delves into the cytotoxic impacts of noble metal-based compounds, such as gold and platinum complexes, often used in cancer therapies. She also studies the protective effects of phytochemicals and natural extracts against oxidative cellular damage. More recently, she has ventured into the field of microalgae biotechnology, investigating these organisms as promising sources of nutraceuticals, pigments, and antioxidants with therapeutic potential. Her research bridges fundamental cell biology with translational applications in medicine and biotechnology.

Award

DMM’s scientific achievements have garnered multiple accolades. In 2014, she was honored with the Best Work of the Year Award for the publication “Fulgione et al” in Journal of Zoology. Two years later, in 2016, her publication in Chemical Communications was selected for the journal’s front and back cover. In 2019, her article in Nanomedicine: Nanotechnology, Biology and Medicine became the most downloaded piece in its category. In 2020, another of her works featured in ChemMedChem was recognized as part of the “Cancer Research Hot Topic Series,” while her collaborative research published in Biochimica et Biophysica Acta – Bioenergetics was highlighted by Elettra Synchrotron Light Laboratory for its scientific impact.

Publication

DMM has published widely in leading journals, with her most impactful works including:

  1. Monti et al., Nanomed: Nanotechnol Biol Med, 2019, 20, 101997 – Most downloaded article in Nanomedicine (Cited by 134 articles)
  2. Petruk et al., ChemMedChem, 2019, 14, 594 – Selected for Cancer Research Hot Topic Series (Cited by 98 articles)
  3. Ferraro et al., Chem Commun, 2016, 52, 9518 – Featured on front and back cover (Cited by 110 articles)
  4. Fulgione et al., J Zool, 2014, 294(2), 122-128 – Awarded Best Work of the Year (Cited by 87 articles)
  5. Ferraro et al., BBA Bioenerg, 2020, 1861, 148236 – Recognized by Elettra Synchrotron (Cited by 65 articles)
  6. Monti et al., Int J Mol Sci, Special Issue: Microalgae Biotechnology, 2022 – Guest editor and author (Cited by 42 articles)
  7. Petruk et al., Molecules, 2021, Special Issue: Antioxidants and Aging – Co-editor and contributor (Cited by 39 articles)

Conclusion

Daria Maria Monti stands out as a dynamic researcher and dedicated educator in the field of biochemical and cellular sciences. Her international collaborations, editorial roles, and mentoring of young scientists reflect her commitment to advancing research and innovation. Her work continues to inspire developments in the understanding of cellular defense mechanisms, therapeutic compound screening, and biotechnology applications, particularly in aging, cancer, and metabolic stress. With a career marked by academic rigor, innovation, and scientific leadership, DMM is a deserving candidate for any recognition celebrating excellence in research.

Mo Linhong | Stroke Rehabilitation | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Mo Linhong | Stroke Rehabilitation | Best Researcher Award

Docter at Capital Medical University Beijing Rehabilitation Hospital, China

Dr. Mo Linhong serves as the Deputy Chief Physician and Director of the Stroke Rehabilitation Department at Capital Medical University Beijing Rehabilitation Hospital. With deep expertise in the fields of cerebrovascular disease management and neurorehabilitation, Dr. Mo has emerged as a key figure in advancing evidence-based stroke recovery practices. His clinical focus spans thrombolytic therapy in acute stages of stroke, long-term rehabilitation of stroke sequelae, and non-invasive neuroregulation. Through a blend of innovative treatment techniques and personalized care, Dr. Mo continues to contribute significantly to improving functional outcomes in stroke patients across China.

Profile

Scopus

Education

Dr. Mo Linhong has undergone rigorous medical and specialist training in neurology and rehabilitation sciences. With a background rooted in clinical medicine, he furthered his academic expertise in stroke recovery mechanisms and neural modulation therapies. His education included advanced coursework and practical exposure to diagnostic techniques such as electroencephalography and functional assessment, which later became central tools in his research and clinical innovations. Supplementing his formal education, Dr. Mo also participated in continuing medical education programs to remain updated with the evolving frontiers in neurorehabilitation and post-stroke care.

Experience

With over a decade of experience in stroke management and rehabilitation, Dr. Mo Linhong has led numerous interdisciplinary clinical programs focused on restoring neurological function and quality of life in stroke survivors. As Director of the Stroke Rehabilitation Department, he has managed both acute and chronic patient populations, facilitated clinical trials, and spearheaded translational initiatives that bridge neurological diagnostics and rehabilitation planning. His leadership roles also include involvement in several consultancy and industry projects aimed at optimizing rehabilitation pathways, and his department has become a model center for non-invasive brain stimulation applications in recovery.

Research Interest

Dr. Mo’s primary research interest lies in stroke rehabilitation, with a strong emphasis on the use of non-invasive neuromodulation techniques such as transcranial magnetic stimulation (TMS) to improve post-stroke functional deficits. He focuses on the intersection of clinical neurophysiology and patient-tailored recovery programs. His work is also centered on cognitive impairment assessment using EEG, development of protocols for evaluating consciousness disorders, and rehabilitation strategies that align with neuroplasticity principles. Dr. Mo is especially committed to designing adaptive and personalized rehabilitation interventions grounded in objective neurodiagnostic findings.

Award

Throughout his professional career, Dr. Mo Linhong has earned recognition for his clinical excellence and research contributions. His achievements include editorial appointments and invited speaker roles at national forums on neurorehabilitation. He has received accolades for his role in deploying innovative clinical solutions that reduce recovery time in post-stroke patients. Notably, his institution has nominated him for multiple excellence awards, and his collaborative patents and medical device contributions are under active consideration for industry impact awards. He is a potential candidate for honors such as the “Best Researcher Award” and “Excellence in Innovation in Neurology.”

Publication

Dr. Mo has authored over 20 peer-reviewed publications, primarily indexed in SCI and Scopus. His articles explore neural regulation therapy outcomes, stroke-related disability metrics, and cognitive assessment models. Below is a selection of notable publications:

  1. Application of Transcranial Magnetic Stimulation in Stroke Recovery, Neural Regeneration Research, 2020 – Cited by 46 articles
  2. EEG Patterns in Post-Stroke Cognitive Dysfunction, Frontiers in Neuroscience, 2021 – Cited by 39 articles
  3. Functional Connectivity Changes in Rehabilitation Patients, Journal of Stroke and Cerebrovascular Diseases, 2019 – Cited by 28 articles
  4. Role of Non-Invasive Neuromodulation in Stroke Sequelae, CNS Neuroscience & Therapeutics, 2022 – Cited by 34 articles
  5. Comparative Analysis of Neuroplasticity Indicators, Brain and Behavior, 2020 – Cited by 21 articles
  6. Neurorehabilitation Protocols for Cognitive Decline, Archives of Physical Medicine and Rehabilitation, 2018 – Cited by 25 articles
  7. Integrated Assessment of Motor and Cognitive Recovery, Journal of NeuroEngineering and Rehabilitation, 2023 – Cited by 18 articles

Conclusion

Dr. Mo Linhong’s contributions to the field of stroke rehabilitation embody a convergence of clinical expertise, research innovation, and a deep commitment to patient-centered care. His work on non-invasive neuromodulation and objective cognitive assessments has not only influenced clinical practices in China but also offered replicable models globally. Through leadership in medical research, development of patents, and editorial responsibilities, Dr. Mo exemplifies the qualities of a transformative medical professional. His multifaceted impact strongly positions him as a commendable nominee for the Best Researcher Award in neurorehabilitation sciences.

Xiaojiang Qin | Natural Products Chemistry‌ | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Xiaojiang Qin | Natural Products Chemistry‌ | Best Researcher Award

Professor at Shanxi Medical University, China

Dr. Qin Xiaojiang is a distinguished professor and doctoral supervisor at Shanxi Medical University, China, where he also serves as the Associate Director of the Department of Science and Technology. With extensive experience in academic leadership and scientific research, he has made a profound impact in the fields of vascular toxicology, environmental exposure, and natural product pharmacology. Dr. Qin also directs the Institute of Environmental Exposure and Vascular Diseases and plays a pivotal role in guiding the Shanxi Provincial Science & Technology Innovation Team. His academic endeavors and leadership contributions have established him as a key figure in medical science research both nationally and internationally.

Profile

Orcid

Scopus

Education

Dr. Qin earned his Ph.D. in Medicine from Shanxi Medical University, where he built a strong foundation in clinical and translational medical research. Further advancing his global academic footprint, he completed a prestigious visiting scholar program at the University of California, San Francisco (UCSF) between 2019 and 2020. His international training enriched his scientific perspective and fostered interdisciplinary collaborations, especially in environmental health and vascular biology.

Experience

Over the years, Dr. Qin has accumulated a wealth of experience in both academic and administrative roles. As the Associate Director of the Department of Science and Technology at Shanxi Medical University, he has overseen various high-impact research initiatives and institutional advancements. He also leads the Institute of Environmental Exposure and Vascular Diseases, where his team conducts pioneering research on the vascular impacts of environmental pollutants. His leadership extends to regional innovation efforts, guiding the Shanxi Provincial Science & Technology Innovation Team in advancing biomedical discoveries.

Research Interest

Dr. Qin’s research primarily explores the pathogenic mechanisms of vascular toxicity resulting from environmental exposures, including tobacco-related and industrial pollutants. He is also deeply involved in the development of population-level tobacco control strategies to mitigate public health risks. Another cornerstone of his research lies in drug discovery derived from bioactive natural products, with the goal of identifying novel therapeutic agents with minimal adverse effects. His interdisciplinary approach bridges molecular toxicology, epidemiology, and pharmacognosy.

Award

Dr. Qin’s scientific excellence has been acknowledged through various grants and leadership recognitions. He has successfully secured three prestigious National Natural Science Foundation of China (NSFC) grants as Principal Investigator, affirming the national importance of his research. Additionally, he has led or co-led more than a dozen provincial, ministerial, and industry-sponsored research projects, underlining his capability in driving innovation and collaborative research in the life sciences.

Publication

Dr. Qin has published extensively, with 69 peer-reviewed articles in SCI/EI-indexed and core journals. His publications reflect his depth of inquiry into toxicological mechanisms and therapeutic discoveries. Select publications include:

  1. Toxicology and Applied Pharmacology (2018) – cited by 42 articles.

  2. Biomedicine & Pharmacotherapy (2019) – cited by 36 articles.

  3. Environmental Research (2020) – cited by 28 articles.

  4. Journal of Ethnopharmacology (2021) – cited by 25 articles.

  5. Frontiers in Pharmacology (2022) – cited by 21 articles.

  6. Scientific Reports (2020) – cited by 19 articles.

  7. International Journal of Molecular Sciences (2023) – cited by 15 articles.
    In addition to research papers, he holds two authorized invention patents and ten utility model patents, showcasing his innovation in translational research and applied technologies.

Conclusion

In conclusion, Dr. Qin Xiaojiang embodies the values of excellence in academic research, innovation, and scientific leadership. His deep commitment to understanding and combating vascular diseases through environmental toxicology and natural product pharmacology has yielded important scientific insights and public health applications. With a robust publication record, international research exposure, and multiple prestigious project leaderships, he stands as an exemplary candidate for any recognition in scientific achievement. His work not only advances medical science but also contributes meaningfully to community health and technological progress.

Bumsoo Ahn | Exercise physiology | Best Researcher Award

Published on by Biotechnology Scientist

Assist. Prof. Dr. Bumsoo Ahn | Exercise physiology | Best Researcher Award

Internal Medicine at Wake Forest University School of Medicine, United States

Dr. Bumsoo Ahn is an Assistant Professor in the Department of Internal Medicine at Wake Forest University School of Medicine, where he holds multiple interdisciplinary appointments, including at the J. Paul Sticht Center for Healthy Aging and Alzheimer’s Prevention, the Comprehensive Cancer Center, and the Graduate School Faculty. With a dynamic career that spans rigorous academic training, collaborative research, and translational geroscience, Dr. Ahn has become a recognized contributor in aging research, skeletal muscle physiology, and mitochondrial bioenergetics. His work is marked by a focus on improving physical and cognitive resilience in aging populations, particularly those affected by chronic diseases such as cancer and sarcopenia. His unique blend of exercise physiology, cellular biology, and translational science makes him an outstanding nominee for awards in aging and biomedical research.

Profile

Orcid

Education

Dr. Ahn received his B.S. in Physical Education from Yonsei University in South Korea in 2004. He continued his graduate studies in the United States, earning an M.A. in Exercise Physiology from the University of North Carolina at Chapel Hill in 2011. He completed his Ph.D. in Exercise Physiology in 2015 at the University of Florida under the guidance of Dr. Leonardo Ferreira, followed by postdoctoral fellowships under Dr. Scott Powers and Dr. Holly Van Remmen, where he developed deep expertise in mitochondrial function and aging-related muscular degeneration. These formative academic experiences laid the groundwork for his later translational research in human resilience and mitochondrial biology.

Experience

Dr. Ahn’s professional experience includes a tenure as Research Assistant Professor at the Oklahoma Medical Research Foundation from 2019 to 2021, where he contributed to the Aging & Metabolism Research Program. Since joining Wake Forest in 2022 as a tenure-track faculty member, he has established himself as a leader in geroscience, directing studies that span mechanistic cellular investigation to clinical resilience modeling in cancer and aging. He plays an active role in multiple institutional advisory committees and serves as co-organizer of the Sticht Center on Aging Biology Conference. His cross-functional engagement reflects his commitment to collaborative and impactful science.

Research Interests

Dr. Ahn’s research interests are primarily centered on aging biology, skeletal muscle function, mitochondrial bioenergetics, and resilience in the context of chronic disease and cancer. He has been especially interested in the role of unacylated ghrelin as a therapeutic strategy to combat muscle weakness and cachexia, a line of inquiry that has attracted major NIH and private funding. His research portfolio demonstrates a deep commitment to understanding how mitochondrial function influences aging and physical performance, with a long-term goal of identifying strategies to delay or reverse age-related decline.

Awards

Throughout his career, Dr. Ahn has received numerous prestigious awards. In 2024 alone, he earned the Rising Star Award at the NIA Stress Tests and Biomarkers of Resilience Conference and a Poster of Distinction at the Translational and LHS Scholar Showcase at Wake Forest. His earlier accolades include the William G. Thurman Award for Outstanding Research Assistant (2020), multiple travel awards from academic societies, and competitive pre-doctoral fellowships. These honors speak to his consistent scientific contributions and emerging leadership in the aging and metabolism research community.

Publications

Dr. Ahn has authored impactful peer-reviewed publications in high-quality journals. A recent 2025 paper in The Journal of Physiology, titled “Mitochondrial haplotype and sex modulate responses to endurance exercise training,” explores genetic and gender-specific responses to physical interventions. His 2024 Free Radical Biology and Medicine article, co-authored with Nguyen et al., examined mouse models for oxidative stress in aging. In Aging Cell (2024), he led a study showing unacylated ghrelin’s protective effects against muscle mass loss. A 2023 publication in Annals of Surgery highlighted his contributions to mitochondrial transplantation in kidney injury, reflecting the translational span of his expertise. These articles, collectively cited in dozens of subsequent studies, reinforce his role as a key voice in bioenergetics and geroscience.

Conclusion

In conclusion, Dr. Bumsoo Ahn exemplifies the qualities of a dedicated and forward-thinking biomedical scientist. His strong foundation in exercise physiology, coupled with his advanced expertise in mitochondrial biology, positions him as a critical contributor to the field of aging research. His multidisciplinary approach, active leadership in collaborative projects, and recognition through national and institutional awards underscore his rising influence. Dr. Ahn continues to advance the science of resilience and aging through innovative research, mentorship, and service to the academic community.

Weiwei Chen | Infectious Diseases | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Weiwei Chen | infectious diseases | Best Researcher Award

Director Technician at Fifth Medical Center of Chinese PLA General Hospital, China

Weiwei Chen is a distinguished expert in infectious disease medicine, currently serving as the Director Technician and Deputy Director of the Institute of Infectious Disease Medicine at the Fifth Medical Center of the General Hospital of the People’s Liberation Army (PLA), China. With over three decades of experience in laboratory diagnostics and infectious disease control, she has become a vital figure in China’s medical defense infrastructure. Her leadership has been instrumental in managing large-scale epidemic responses, both domestically and internationally. Through her technical guidance, scholarly output, and fieldwork, Chen has demonstrated a sustained commitment to advancing public health, medical training, and disease surveillance, making her a leading candidate for recognition in the field of infectious disease research and control.

Profile

Scopus

Education

Chen’s educational foundation is rooted in medical diagnostics and epidemiology. She earned her bachelor’s degree in Laboratory Medicine from the Third Military Medical University in 1990, providing her with core clinical and laboratory skills. Pursuing further specialization, she obtained her master’s degree in Clinical Laboratory Diagnostics from the same university in 2001, which refined her expertise in pathogen detection and diagnostic methodologies. In 2007, she completed her doctoral studies in Infectious Diseases at the Chinese PLA Medical School, focusing on disease transmission dynamics and immunological responses to viral outbreaks. This progression illustrates her enduring commitment to scientific excellence and specialized knowledge.

Experience

Over the course of her professional career, Chen has assumed numerous technical and leadership roles, culminating in her current position as Deputy Director of the Institute of Infectious Disease Medicine at the PLA’s Fifth Medical Center. She oversees pathogen surveillance, laboratory operations, and technical training programs tailored to military and civilian health contingencies. Her field experience includes serving as the head of the fifth group of the Chinese Military Medical Expert Group (CMMEG) dispatched to Sierra Leone from 2019 to 2022. Under her leadership, the group made significant contributions to local COVID-19 mitigation strategies in collaboration with the Republic of Sierra Leone Armed Forces. Her proactive involvement in epidemic control and her capacity to translate scientific research into applied medical strategies underscore her value as a national and international asset in disease prevention.

Research Interest

Chen’s research centers on the immune mechanisms and therapeutic targets associated with high-impact infectious diseases such as COVID-19, influenza, and adenovirus. She has a deep interest in understanding how viral pathogens evade immune responses and identifying potential molecular interventions. In addition to this, she investigates the mechanisms of pathogen transmission in group settings, especially in military environments, aiming to create effective strategies for outbreak prediction and containment. Her work seamlessly integrates laboratory diagnostics, immunology, and field epidemiology to develop evidence-based responses to emerging public health threats.

Award

Weiwei Chen has been recognized with two Science and Technology Progress Awards by the Chinese PLA, highlighting her contributions to national health security and research excellence. Her leadership in international medical missions, particularly in Sierra Leone during the COVID-19 crisis, earned her high praise from the Sierra Leone Armed Forces. These honors underscore her commitment to public health, international collaboration, and the advancement of medical science in service of military and civilian populations alike.

Publication

Chen has published over 80 academic papers, including 17 in SCI-indexed journals. Selected key publications include:

  1. Immune profiling in severe COVID-19 patients (2020), Science Translational Medicine, cited by 350 articles.

  2. Clinical features of adenovirus pneumonia outbreaks (2021), Journal of Infection, cited by 112 articles.

  3. Pathogen detection using multiplex PCR in military cohorts (2022), Frontiers in Microbiology, cited by 75 articles.

  4. Strategies for laboratory biosafety in pandemic response (2019), Military Medical Research, cited by 63 articles.

  5. Comparative study on antiviral treatments in influenza (2021), Virology Journal, cited by 58 articles.

  6. Field diagnostics innovation during Ebola resurgence (2020), Tropical Medicine and Health, cited by 49 articles.

  7. Adjuvant therapy targets in viral pneumonia (2023), International Journal of Infectious Diseases, cited by 37 articles.
    These works collectively reflect her expertise in virology, diagnostic innovation, and field medicine.

Conclusion

Weiwei Chen’s professional journey exemplifies dedication to the advancement of infectious disease research, diagnostics, and international cooperation in public health emergencies. Her educational achievements, research contributions, and field leadership mark her as a pivotal figure in medical science, particularly in the strategic domains of epidemic preparedness and military medicine. Through a career characterized by scientific rigor and humanitarian service, she continues to impact global health security and stands as a compelling nominee for any award honoring excellence in infectious disease research and public health.

Somayeh Sharafi Zamir | Biopolymers | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Somayeh Sharafi Zamir | Biopolymers | Best Researcher Award

Scientist at UWMadison, United states

Farnaz Sharafi is a dedicated polymer scientist with deep expertise in rheology, polymer processing, and the characterization of advanced materials. Her work lies at the intersection of scientific innovation and sustainable application, where she leverages her knowledge to improve material performance and optimize production processes. With a strong foundation in polymer formulation, she specializes in the development of recyclable, biodegradable, and high-performance materials for flexible packaging, coatings, and thermal applications. Her technical acumen is complemented by effective communication and collaboration with academic and industrial stakeholders, enabling the translation of laboratory research into scalable solutions across various sectors.

Profile

Scopus

Education

Sharafi’s academic journey reflects a strong commitment to materials innovation, starting with a Bachelor’s degree in Materials Science and Engineering from Isfahan, Iran (2008–2011), where she investigated the use of polyethylene terephthalate (PET) in cement reinforcement. She then pursued her Master’s in the same discipline (2011–2013), exploring microstructural and phase analysis in Cordierite-Si₃N₄ composites. Her doctoral studies in Chemical Engineering at the University of Sherbrooke, Canada (2015–2020), focused on polylactic acid (PLA)/starch nanocrystal nanocomposites. Her thesis addressed key areas such as crystallinity, gas permeability, and biodegradability, laying the foundation for a career focused on eco-design and sustainable polymer systems.

Experience

Her professional trajectory began as a Research Assistant at the University de Sherbrooke (2011–2013), where she designed and characterized starch nanocrystals (SNCs) for food packaging, advancing green chemistry applications in biodegradable polymers. She subsequently joined Polytechnique de Montréal as a Research Fellow (2020–2021), where she led the development of antiviral food packaging during the COVID-19 pandemic—efforts that culminated in a patent. At McGill University (2021–2022), Sharafi worked on green pigment synthesis using cellulose nanocrystals (CNCs) for cosmetic applications. Her industrial experience includes a tenure as a Polymer Scientist at C-Therm in New Brunswick (2022–2023), where she led R&D projects on thermal properties of polymer nanocomposites and advanced characterization techniques. Since 2023, she has served as a Research and Development Scientist at Polytechnique de Montréal, where she leads the creation of sustainable, multilayer polymer structures, with a focus on returnable and compostable packaging technologies.

Research

Sharafi’s research interests span polymer nanocomposites, thermal and mechanical analysis, biobased materials, and smart packaging systems. She is particularly focused on understanding viscoelastic behavior and tailoring material properties through rheological, structural, and thermal characterization. She applies these insights to develop smart, active, and intelligent polymer systems that improve mechanical integrity, extend shelf-life, and offer functional advantages for industrial applications. Her work in electrospinning, reactive extrusion, and solution casting has supported innovation in antimicrobial packaging, thermally conductive films, and biopolymer reinforcement.

Awards

Throughout her career, she has been honored with several prestigious awards, including a research grant from the Centre québécois des matériaux fonctionnels (CQMF) funded by the Fonds de Recherche du Québec – Nature et Technologie (2013–2016), and a Mitacs Research Fellowship (2022–2023). She also received the Best Student Research Award from the Iran Nanotechnology International Council, recognizing her outstanding contributions to sustainable polymer science.

Publications

Sharafi has published in several high-impact journals, with her research drawing attention in both academic and industrial communities. Notable publications include:

  1. Sharafi, F., et al. (2023). “Enhanced Thermal Conductivity of Nanocellulose–CNT Composites for Sustainable Packaging.” Journal of Applied Polymer Science. [Cited by 12 articles]
  2. Sharafi, F., et al. (2022). “Green Pigment Production from Cellulose Nanocrystals for Cosmetic Applications.” ACS Sustainable Chemistry & Engineering. [Cited by 8 articles]
  3. Sharafi, F., et al. (2021). “Antiviral Packaging Film Development for Food Safety Applications.” Food Packaging and Shelf Life. [Cited by 15 articles]
  4. Sharafi, F., et al. (2020). “Biodegradability and Barrier Properties of PLA–Starch Nanocrystal Composites.” Polymer Degradation and Stability. [Cited by 20 articles]
  5. Sharafi, F., et al. (2018). “Thermomechanical Properties of Recycled LDPE Nanocomposites.” Journal of Polymers and the Environment. [Cited by 9 articles]
  6. Sharafi, F., et al. (2017). “Effect of CNC Content on PLA Packaging Films.” Carbohydrate Polymers. [Cited by 11 articles]
  7. Sharafi, F., et al. (2016). “Green Synthesis of SNCs and their Use in Biodegradable Polymers.” International Journal of Biological Macromolecules. [Cited by 14 articles]

Conclusion

In conclusion, Farnaz Sharafi exemplifies a scientist with a vision for sustainable materials innovation. Her interdisciplinary research blends fundamental science with real-world applications, and her contributions to biopolymer packaging, pigment engineering, and nanocomposite design demonstrate both technical excellence and societal relevance. With extensive experience across academia and industry, she remains committed to advancing sustainable solutions through collaborative, high-impact research and development. Her career continues to bridge material science innovation with environmental responsibility, positioning her as a nominee of merit for awards in the field of polymer science and green technology.

Estefan Fonseca | Bioremediation | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Estefan Fonseca | Bioremediation | Best Researcher Award

Researcher at Universidade Federal Fluminense, Brazil

Estefan Monteiro da Fonseca is a distinguished researcher and academic with over two decades of experience in oceanographic and environmental geosciences. He currently serves as a Professor Adjunto I at Universidade Federal Fluminense (UFF), where he also operates as a full-time researcher at the Marine Geology Laboratory (LAGEMAR). Recognized nationally through a Productivity Researcher fellowship (CNPq Level 2), Fonseca is known for his multidisciplinary work in environmental monitoring, marine pollution, and the biogeochemical behavior of heavy metals. His contributions extend to international collaborations, editorial responsibilities, and active involvement in significant coastal and estuarine environmental projects, emphasizing his leadership and innovation in applied marine geosciences.

Profile

Orcid

Education

Fonseca’s academic foundation includes a Doctorate in Geology (2008) and a Master’s degree in Geology (2004), both from Universidade Federal Fluminense, where he also completed a postdoctoral fellowship in Environmental Geology in 2010. His doctoral research included a sandwich program at Queen’s University Belfast, reflecting his international academic engagement. His early training began with a degree in Oceanography from Universidade do Estado do Rio de Janeiro in 1999, with a focus on coastal water quality. These progressive academic stages have grounded his expertise in the complex interactions between chemical, biological, and geological factors in marine systems.

Experience

Professionally, Fonseca’s trajectory includes academic and technical roles that bridge academia and applied environmental science. He began his career as a technical environmental consultant at Labagua, followed by leadership in project management at Ecology & Environment do Brasil from 2006 to 2013, where he managed environmental licensing initiatives for the oil, gas, and port sectors. Since 2009, he has been integral to the academic and research activities at UFF, teaching courses in marine pollution and applied geology while mentoring graduate students. He has also served in visiting and substitute professor capacities at several institutions, including UERJ and FAMATH.

Research Interests

Fonseca’s research interests center on marine pollution, particularly the behavior and fractionation of heavy metals in sediments and their bioavailability to microorganisms. His scientific inquiries extend to the impacts of microplastics and endocrine-disrupting chemicals in aquatic ecosystems. His projects often apply multidisciplinary approaches combining geochemistry, oceanography, and microbiology. Fonseca also engages in bioassay techniques for toxicity assessment and supports the development of geochemical proxies for environmental monitoring in industrialized coastal zones.

Awards

Among his many accolades, Fonseca is the recipient of a CNPq Level 2 Productivity Researcher Grant, a prestigious recognition of sustained research excellence in Brazil. His international exposure and scholarly activities have earned him editorial roles in multiple peer-reviewed journals, such as Revista Eletrônica Sistemas & Gestão and Environmental Monitoring and Assessment. Additionally, he is Editor-in-Chief of the journal Sustainability & Governance, showcasing his commitment to scientific dissemination and environmental policy integration.

Publications

Fonseca’s recent high-impact publications demonstrate the depth and relevance of his work. Selected examples include:

  1. Gaylarde, C. C. & Fonseca, E. M. (2025). Biofertilization and Bioremediation. Micro, 5, 18.
  2. Giarrizzo et al., including Fonseca, E. M. (2025). MICROMar Project. Limnology and Oceanography Bulletin, 34, 48–51.
  3. De Souza et al., including Fonseca, E. M. (2024). Bioaccumulation of PAHs in marine bivalves. Marine Pollution Bulletin, 199, 115900. (Cited by 3)
  4. Gaylarde, C. C.; Baptista Neto, J. A.; Fonseca, E. M. (2024). Indoor Airborne Microplastics. Microplastics, 3, 653–670. (Cited by 1)
  5. Pierri et al., including Fonseca, E. M. (2024). Effective microorganisms in shrimp farming. Acta Scientiarum. Biological Sciences, 46, e69227.
  6. Fonseca, E. M. et al. (2023). Microplastics in the cryosphere. Water Emerging Contaminants & Nanoplastics, 2, 1.
  7. Almeida et al., including Fonseca, E. M. (2023). Microplastic migration. Micro, 2, 62–77. (Cited by 17)

Conclusion

In conclusion, Estefan Monteiro da Fonseca exemplifies scientific excellence through his integrative approach to environmental geosciences, his prolific research output, and his dedication to both academic and applied scientific communities. His contributions address pressing global challenges such as pollution, climate change, and sustainable marine resource management, making him a compelling nominee for any award recognizing impactful scientific leadership.

Yu Zhao | Crop developmental biology | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Yu Zhao | Crop developmental biology | Best Researcher Award

Professor at Huazhong Agricultural University, China

Professor Yu Zhao is a distinguished scientist and academic leader in the field of plant molecular biology, with a focus on rice developmental biology. As a renowned researcher, she has made groundbreaking contributions to understanding the genetic and epigenetic regulation of crown root development in rice. Her innovative work explores how plants adapt to environmental challenges, ultimately aiming to improve crop resilience and productivity. With a prolific publication record in leading scientific journals, Professor Zhao continues to be a driving force in agricultural biotechnology.

Profile

Orcid

Education

Professor Zhao earned her Ph.D. in Plant Biology, where she developed a solid foundation in molecular genetics and developmental biology. During her doctoral studies, she began investigating the regulatory networks involved in root architecture, laying the groundwork for her future research in rice morphogenesis. Her academic training integrated advanced genomic technologies and epigenetic tools, preparing her to explore complex plant development mechanisms. Over the years, she has enriched her expertise through continued learning and collaboration across international research institutions.

Experience

Currently serving as a Professor at the National Key Laboratory of Crop Genetic Improvement, Professor Zhao leads a dynamic research team focused on rice organogenesis. With a career spanning over a decade in plant molecular biology, she has mentored numerous graduate students and postdoctoral fellows, fostering a collaborative and innovative research environment. Her experience encompasses gene expression analysis, chromatin remodeling, and high-throughput genomic approaches. She plays a pivotal role in national crop improvement initiatives and frequently contributes to international symposia and collaborative projects aimed at advancing food security.

Research Interest

Professor Zhao’s research centers on the molecular mechanisms governing crown root development in rice, which is vital for anchorage and nutrient uptake. She is particularly interested in how transcription factors such as WOX11, LBD16, and ERF3, along with chromatin modifiers like histone acetyltransferases and demethylases, control root initiation and elongation. Her studies also examine how environmental stresses, including heat and cold, influence root system development at the epigenetic level. Using approaches such as spatial transcriptomics and methylome profiling, her lab elucidates how rice plants adapt their root architecture to changing environments, with the goal of designing resilient crop varieties.

Award

Professor Zhao has received multiple honors for her exceptional contributions to plant science. Her innovative research has not only advanced theoretical understanding but also yielded practical solutions for crop improvement. She holds several national and international patents related to key regulatory genes in rice development and stress adaptation. These patents reflect her commitment to translational research and her ability to convert fundamental discoveries into applicable technologies for sustainable agriculture.

Publication

Professor Zhao has authored numerous influential publications. Below are seven selected peer-reviewed papers that exemplify the breadth and impact of her work:

  1. Ma et al. (2025), Nature Plants – Demonstrated the regulation of OsECT3 via lysine acetylation under cold stress in rice. (Cited by 21 articles)
  2. Zhang et al. (2025), New Phytologist – Explored the uORF-HsfA1a-WOX11 pathway in crown root development. (Cited by 18 articles)
  3. Zhong et al. (2025), Molecular Plant – Identified spatial transcriptomic adaptations in rice roots under dryland conditions. (Cited by 30 articles)
  4. Geng et al. (2024), Plant Cell – Revealed the cooperation of WOX11, LBD16, and JMJ706 in root development. (Cited by 42 articles)
  5. Chen et al. (2024), Cell Reports – Linked histone deacetylase activity to heat stress tolerance in rice. (Cited by 25 articles)
  6. Liu et al. (2023), Nature Communications – Reported DNA methylation reprogramming in the rice zygote. (Cited by 50 articles)
  7. Li et al. (2023), EMBO Journal – Unveiled chromatin modification mechanisms behind DELLA-mediated repression. (Cited by 33 articles)

These publications, many co-authored with global experts in plant genetics, demonstrate Professor Zhao’s leadership in both fundamental and applied plant biology.

Conclusion

In conclusion, Professor Yu Zhao is a visionary female scientist whose career exemplifies excellence in research, innovation, and mentorship. Her extensive contributions to understanding rice root development and environmental adaptation have far-reaching implications for crop improvement and global food sustainability. As a thought leader in plant epigenetics and developmental biology, she bridges the gap between laboratory research and agricultural application. Her dedication to translational science, strong publication record, and portfolio of patented technologies make her an outstanding candidate for prestigious recognitions in biotechnology and plant science research.

Gilles Pagès | Breast Cancer | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Gilles Pagès | Breast Cancer | Best Researcher Award

Director of Research exceptional class at INSERM, France

Dr. Gilles Pagès is a senior cancer research scientist with a long-standing career in molecular and cellular biology, prominently contributing to oncology through translational and experimental research. Currently a DRCE-level researcher at INSERM and principal investigator at IRCAN, he also serves as a consultant to the Centre Scientifique de Monaco. Since completing his PhD in 1990 and his habilitation in 1994 at the University of Nice, he has consistently worked at the intersection of angiogenesis, resistance mechanisms in cancer therapy, and vascular biology. Dr. Pagès holds an international reputation, underscored by memberships in key scientific boards and a prolific record of publications, grants, and patents.

profile

Orcid

Education:

Dr. Pagès received his PhD in molecular and cellular biology in 1990 from Nice, France, and earned his Habilitation à diriger des recherches in 1994. His early academic trajectory was marked by a steady rise through French research ranks, ultimately achieving the highest level as DRCE at INSERM in 2024. His solid foundational education and continuous professional advancement have positioned him as an expert in translational cancer research.

Experience:

From 1990 to 2007, he served as Assistant Professor, progressing to DR2 INSERM (2007–2013), DR1 INSERM (2013–2023), and finally DRCE INSERM from 2024. At IRCAN, Dr. Pagès has led innovative cancer research and contributed extensively to mentorship and institutional development. He is also a consultant for the Centre Scientifique de Monaco and has acted as an expert for pharmaceutical companies such as Roche, Bayer, Ipsen, and BMS. His international influence is reflected in invitations to over 30 scientific conferences and roles in organizing major congresses like the Biennale de Cancérologie de Monaco.

Research Interests:

Dr. Pagès’ research focuses on tumor angiogenesis, resistance to anti-angiogenic therapy, the tumor microenvironment, renal cell carcinoma, and therapeutic targeting of cytokine and chemokine pathways. He has contributed significantly to understanding CXCL-CXCR signaling, neuropilins, and metabolic vulnerabilities in cancer. His team investigates translational approaches that link mechanistic insights with clinical applications, bridging gaps between bench and bedside.

Awards:

His pioneering work has garnered several accolades, including the Grand Prix Ruban Rose for breast cancer research (2015), the Prince Albert I° Award from the National Academy of Medicine (2018), the Amgen Foundation Award (2021), and the prestigious Grand Prix Jean Valade from Fondation de France (2023–2024). These honors underscore his contributions to advancing cancer research and therapeutic innovation.

Publications:

Dr. Pagès has authored over 160 publications and holds 14 patents. Below are 7 selected key publications:

  1. Teisseire M et al., 2025, Cancer Research: “De Novo Serine Synthesis is a Metabolic Vulnerability that can be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma” – This study, cited in 12 articles, explores therapeutic resistance mechanisms in renal cancer.
  2. Sarlak S, Pagès G, Luciano F, 2025, Cancer Treatment Reviews: “Enhancing radiotherapy techniques for Triple-Negative Breast Cancer” – A collaborative review shaping future radiotherapy strategies.
  3. Sirera J et al., 2024, Journal of Experimental & Clinical Cancer Research: “Disrupting USP39 deubiquitinase function…” – Cited in 20+ papers, it offers novel pathways in myeloma treatment.
  4. Montemagno C et al., 2024, J Exp Clin Cancer Res: “CXCR2 as a therapeutic target in renal cell carcinoma” – Received significant attention with over 30 citations.
  5. Montemagno C et al., 2023, Molecular Oncology: “VEGF splice variants as therapeutic targets” – A foundational paper in RCC therapy cited by leading cancer biologists.
  6. Giuliano S et al., 2023, Autophagy: “Autolysosomal defects in Alzheimer and Parkinson disease” – Cross-disciplinary impact with 18 citations.
  7. Brest P et al., 2023, British Journal of Cancer: “Checkpoint inhibitors and anti-angiogenic agents: a winning combination” – Widely cited for its relevance in immunotherapy integration.

Conclusion:

Dr. Gilles Pagès stands as a distinguished figure in cancer biology, contributing extensively to both basic research and its clinical translation. With a career that spans over three decades, his work bridges molecular insights with therapeutic advances, particularly in renal cell carcinoma and angiogenesis. His strategic involvement in research networks, mentorship, teaching, and startup creation reflects his commitment to innovation and collaboration. Dr. Pagès continues to lead impactful projects, publish influential research, and inspire new generations of scientists across Europe and beyond.

Lingfei Han | Gynecologic Oncology | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Dr. lingfei han | gynecologic oncology | Best Researcher Award

Associate professor at Tongji university, China

Lingfei Han is a dedicated medical professional and accomplished researcher in the field of gynecological oncology. Currently serving as an attending surgeon and instructor at the Shanghai First Maternity and Infant Hospital affiliated with Tongji University School of Medicine, Han has cultivated a dual career in both clinical practice and biomedical research. With a strong foundation in clinical medicine and molecular biology, he has developed a specialized focus on cancer immunotherapy, tumor microenvironment, and immunoregulatory pathways relevant to cervical and ovarian cancers. His extensive experience in translational oncology has led to multiple impactful publications and research projects supported by national funding agencies.

Profile

Scopus

Education:

Lingfei Han pursued his medical education entirely at Tongji Medical College of Huazhong University of Science and Technology, where he earned his Bachelor of Medicine degree in Clinical Medicine in 2003. He subsequently deepened his understanding of disease mechanisms through a Master of Science degree in Molecular Biology, completed in 2006. Motivated by a growing interest in gynecologic malignancies, he undertook doctoral studies in Gynecological Oncology and obtained his Ph.D. in 2009. This academic trajectory provided a robust scientific and clinical foundation for his future career in oncologic surgery and immunotherapy research.

Experience:

Since July 2009, Han has been part of the OB/GYN Department at the Shanghai First Maternity and Infant Hospital, beginning his tenure as a resident surgeon and advancing to the position of attending surgeon. Over the years, he has developed proficiency in a range of surgical techniques and has been actively involved in the care and treatment of patients with gynecological cancers. Alongside his clinical responsibilities, he has served as an instructor, mentoring medical students and junior clinicians while continuously participating in laboratory-based cancer research projects.

Research Interest:

Han’s research primarily focuses on the immunological aspects of gynecological cancers, especially cervical and ovarian cancers. He has developed expertise in molecular and cell biology techniques, including recombinant adeno-associated virus construction, flow cytometry, and immunohistochemistry. His major research interests include the immune escape mechanisms in cancer via pathways such as BTLA-HVEM and PD-1/PD-L1 signaling, the development of in vivo tumor models, and cancer gene therapy strategies. Notably, his work includes the use of animal models to simulate metastatic progression and immune modulation, as well as the development of gene panels and nanomedicine platforms for targeted cancer therapy.

Awards:

Lingfei Han has been the recipient of several prestigious research grants and recognitions throughout his career. His notable funded projects include the study of soluble BTLA’s role in immune surveillance evasion in cervical cancer, supported by the Natural Science Foundation of China (2011–2013), and an investigation into its mechanisms in ovarian cancer, funded by the Youth Science and Technology Phosphorus Program of Shanghai. Additionally, his early career promise was acknowledged through Tongji University’s Youth Outstanding Personnel Training Plan grant for exploring BTLA-HVEM signaling in immune escape (2009–2011).

Publications:

Han has authored and co-authored numerous impactful scientific articles. Selected publications include:

  1. EIF4A3-regulated circ_0087429 reverses EMT in cervical cancer via miR-5003-3p/OGN axis, J Exp Clin Cancer Res, 2022 (Cited by over 40 articles).
  2. Myeloid-derived suppressor cells interact with B10 cells via BAFF/BAFF-R in cervical cancer, Cancer Immunol Immunother, 2022 (Cited by 30+).
  3. A Pyroptosis-Related Gene Panel in Cervical Cancer, Front Oncol, 2022 (Cited by 25).
  4. CMTM6 Overexpression in Ovarian Cancer Immune Infiltration, Front Mol Biosci, 2022 (Cited by 18).
  5. PLGA nanoparticles for co-delivery of drugs in ovarian cancer, Drug Des Devel Ther, 2019 (Cited by 35).
  6. CD163+ and CD68+ macrophages in HPV-related cervical cancer, J Cancer, 2017 (Cited by 50+).
  7. Soluble BTLA boosts HSP70 vaccine-induced tumor immunity, J Immunol, 2009 (Cited by 60+).

Conclusion:

Through a well-balanced integration of clinical care and innovative research, Lingfei Han has made substantial contributions to the understanding and treatment of gynecologic cancers. His work in immune modulation and cancer therapeutics not only advances scientific knowledge but also holds tangible benefits for clinical applications in oncology. His continuous efforts in mentoring, publishing, and research underscore a career committed to translational science and improving patient outcomes. Han’s trajectory demonstrates the importance of a rigorous academic background, interdisciplinary collaboration, and sustained inquiry into cancer immunology.